Medicina
Departamento
Taichung Veterans General Hospital
Taichung, TaiwánPublicaciones en colaboración con investigadores/as de Taichung Veterans General Hospital (8)
2024
-
Atezolizumab monotherapy versus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis from a randomised, controlled, phase 3 study
The Lancet Oncology, Vol. 25, Núm. 1, pp. 46-61
-
Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 study
The Lancet Oncology, Vol. 25, Núm. 1, pp. 29-45
2023
2022
-
Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021
Transplant Infectious Disease, Vol. 24, Núm. 6
2017
2014
-
Angiogenesis inhibitor therapies for advanced renal cell carcinoma: Toxicity and treatment patterns in clinical practice from a global medical chart review
International Journal of Oncology, Vol. 44, Núm. 1, pp. 5-16
-
DIABETES-SPECIFIC NUTRITION ALGORITHM: A TRANSCULTURAL PROGRAM TO OPTIMIZE DIABETES AND PREDIABETES CARE
CLINICAL NUTRITION: THE INTERFACE BETWEEN METABOLISM, DIET, AND DISEASE (CRC PRESS-TAYLOR & FRANCIS GROUP), pp. 209-239
-
Randomized, placebo-controlled, phase III trial of sunitinib plus prednisone versus prednisone alone in progressive, metastatic, castration-resistant prostate cancer
Journal of Clinical Oncology, Vol. 32, Núm. 2, pp. 76-82